The Claim
The efficacy of zinc acetate lozenges in treating the common cold is not modified by age (17-61 years), sex, race, allergy status, smoking, or baseline common cold severity, indicating consistent benefits across these demographic and clinical subgroups.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Zinc acetate lozenges work just as well for treating colds in people of different ages, genders, races, allergies, smoking habits, or how bad their cold is when they start.
See the scientific wording
Zinc acetate lozenge efficacy is not modified by age (17-61 years), sex, race, allergy status, smoking, or baseline common cold severity, indicating consistent benefits across these demographic and clinical subgroups.
What the research says
1 studyThe study looked at zinc acetate lozenges and found they work equally well for people of different ages, genders, races, and other factors, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.